Financial Times Europe’s Leading Patent Law Firms 2025

ARTICLE SUMMARY

Potter Clarkson has been recognised in the Financial Times’ 2025 ranking of Europe’s Leading Patent Law Firms, based on recommendations from more than 3,300 clients and peers.

authors
No items found.
Related Services
Related Industries

Potter Clarkson has been recognised in the Financial Times’ 2025 ranking of Europe’s Leading Patent Law Firms, based on recommendations from more than 3,300 clients and peers.

We are one of only a small number of firms to be especially recommended in all six areas of industrial expertise:

  • Biotechnology, Food & Healthcare (Gold)
  • Electrical Engineering & Physics (Gold)
  • IT & Software (Gold)
  • Chemistry & Pharmacy (Silver)
  • Mechanical Engineering (Silver)
  • Materials & Nanotechnology (Bronze)

This recognition reflects not just the strength of our technical expertise but also our collaborative approach, our focus on excellence and our commitment to helping clients maximise the commercial value of their ideas.

It’s also a moment to recognise the contribution of colleagues across the firm.

Thank you to everyone who made this possible.

Related News

Potter Clarkson ranked in Managing IP's IP STARS 2026

Potter Clarkson ranked in Managing IP's IP STARS 2026

Combination therapies: IP considerations for synergistic biologic products

Combination therapies: IP considerations for synergistic biologic products

Perfect storm - four drivers behind the mRNA litigation wave

Perfect storm - four drivers behind the mRNA litigation wave

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Patent landscape and freedom-to-operate analysis for RNA-based therapies: identifying IP risks early

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Kodak v FujiFilm: the Court of Appeal confirms UPC’s long-arm jurisdiction

Comparing EPC Article 53(a) and US patent law in gene editing ethics

Comparing EPC Article 53(a) and US patent law in gene editing ethics

EPO Board of Appeal refers claim interpretation and added matter questions

EPO Board of Appeal refers claim interpretation and added matter questions

Creating an effective IP strategy for CAR-T

Creating an effective IP strategy for CAR-T

See All News